Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

tropical diseases

This page shows the latest tropical diseases news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Egatan gains US approval for neglected tropical disease

Novartis’ Egatan gains US approval for neglected tropical disease

US approval removes barrier to greater access. The FDA has given its seal of approval to Novartis’ Egatan, which becomes the first approved treatment in the US for tropical disease fascioliasis. ... said Dr Mwelecela Malecela, Director of the

Latest news

  • Pfizer signs mRNA flu vaccine deal with BioNTech Pfizer signs mRNA flu vaccine deal with BioNTech

    number of diseases, including Zika and rabies. ... Last year, a research team from the University of Munich’s Department of Infectious Diseases and Tropical Medicine moved a rabies vaccine developed by CureVac into what it said was the

  • The power of pharma businesses to drive social change The power of pharma businesses to drive social change

    For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases

  • Novartis' Swiss head of operations reveals job cuts Novartis' Swiss head of operations reveals job cuts

    and said it planned to move its tropical diseases research from Singapore to California.

  • Sanofi pays $245m for FDA priority review voucher Sanofi pays $245m for FDA priority review voucher

    Gilead Sciences bought one from Canada's Knight Therapeutics last year that was awarded by the FDA in return for developing a drug for a neglected tropical disease. ... The rising price also reflects the scarcity of the vouchers, which so far are only

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.

More from news
Approximately 4 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Reaching new heights Reaching new heights

    The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will

  • Pharma deals in August 2015 Pharma deals in August 2015

    $65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in

  • Pharma deals during November 2014 Pharma deals during November 2014

    from ten months down to six). Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. One of 16 tropical ... diseases that qualify is leishmaniasis, for which Knight's Impavido

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Quick links

Infographics

Multimedia